143
Participants
Start Date
July 31, 2012
Primary Completion Date
July 31, 2014
Study Completion Date
April 30, 2015
Ipilimumab
Best Supportive care (BSC)
Local Institution, Taipei
Local Institution, Taipei
Nyu Clinical Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
Local Institution, Milan
Local Institution, Madrid
Local Institution, Madrid
Local Institution, Toulouse
Mount Sinai Medical Center, Miami Beach
Local Institution, Montpellier
Local Institution, Rennes
Local Institution, Padua
Local Institution, Florence
Local Institution, Mainz
Local Institution, Pisa
The University Of Texas Md Anderson Cancer Center, Houston
Local Institution, Singapore
Local Institution, Singapore
Local Institution, Kitaadachi-gun
Local Institution, Saku-shi
Local Institution, Nagoya
Local Institution, Osaka-sayama-shi
Local Institution, Nice
Local Institution, Hong Kong
Local Institution, Roma
Local Institution, Katowice
Local Institution, Krakow
Local Institution, Lodz
Local Institution, Olsztyn
Local Institution, Moscow
Local Institution, Gyeonggi-do
Local Institution, Gyeonggi-do
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Barcelona
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY